ArticleAmerican journal of cancer research2025

Efficacy and safety of first-line cetuximab therapy for older patients (aged ≥ 70 years) with

Ching-Wen Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.